Sunday Times (Johannesburg) - February 27, 2008
Candy Guvi
The Scholar Ship, which is carrying 200 students and faculty from 35 countries, will sponsor five South African university students as part of an international R15-million bursary for 2007/2008.
The world's first floating university offers various courses including international business, international communications, global cultures and social change.
The maiden voyage was in September last year, from Greece and ended in December.
The ship is now in its second semester, each semester voyage lasts 16-weeks.
The students aboard the ship left from Hong Kong on December 23, and will continue their voyage across four continents with the local students.
From Cape Town, the students will visit the Cape Verde Islands, Barcelona, Istanbul and Lisbon. The last stop will be Amsterdam.
Adrian Strydom, director of academic programmes at the University of Cape Town, said the university would present a two-day HIV-Aids research workshop for the visiting students and their lecturers, in partnership with the Scholar Ship.
He said the main objective of the programme was the exchange of research into global socio-economic issues, including the HIV-Aids workshop.
"One of the key discussions will be the comparison between how HIV-Aids has been approached in India and South Africa.
"Post-graduate students pursuing master's and PhD degrees have also been invited to engage and participate in the workshops," Strydom said.
Ashley Deiser, spokesman for Scholar Ship, said the selection criteria to get on the ship were based on academic merit.
Marcus Brewster Publicity, which arranged the Scholar Ship visit, said the unique concept was a first for South Africa's tertiary education.
The company said the main goal was to raise student awareness about the global village.
The 16-week academic programme is also meant to enhance the level of inter-cultural competence among students as well at their leadership qualities.
080227
ST080209
Copyright © 2008 - The Sunday Times. Reproduction of this article (other than one copy for personal reference) must be cleared through the Sunday Times Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .